Stoneridge Investment Partners’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,712	Closed	-$5K	–	145
2025 Q1	$5K	Hold	10,712	–	–	﹤0.01%	115
2024 Q4	$5K	Buy	+10,712	New	+$5K	﹤0.01%	135